Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2001-8-6
pubmed:abstractText
In patients with hypogammaglobulinemia, substitution with immunoglobulin is the treatment of choice to reduce both frequency and severity of bacterial infections. Even with treatment, however, infections still occur in these patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0003-4819
pubmed:author
pubmed:issnType
Print
pubmed:day
7
pubmed:volume
135
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
165-74
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11487483-Adolescent, pubmed-meshheading:11487483-Adult, pubmed-meshheading:11487483-Agammaglobulinemia, pubmed-meshheading:11487483-Aged, pubmed-meshheading:11487483-Bacterial Infections, pubmed-meshheading:11487483-Child, pubmed-meshheading:11487483-Child, Preschool, pubmed-meshheading:11487483-Cross-Over Studies, pubmed-meshheading:11487483-Double-Blind Method, pubmed-meshheading:11487483-Drug Administration Schedule, pubmed-meshheading:11487483-Female, pubmed-meshheading:11487483-Humans, pubmed-meshheading:11487483-Immunoglobulin A, pubmed-meshheading:11487483-Immunoglobulin G, pubmed-meshheading:11487483-Immunoglobulin M, pubmed-meshheading:11487483-Immunoglobulins, Intravenous, pubmed-meshheading:11487483-Infant, pubmed-meshheading:11487483-Male, pubmed-meshheading:11487483-Middle Aged, pubmed-meshheading:11487483-Recurrence
pubmed:year
2001
pubmed:articleTitle
The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial.
pubmed:affiliation
CLB, Medical Department, Plesmanlaan 125, 1066 CX Amsterdam, the Netherlands. H_Eijkhout@CLB.nl
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't